TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
280,772
|
338,609
|
293,833 |
| Earnings before taxes |
42,404
|
103,340
|
98,713 |
| Total assets |
486,210
|
462,518
|
422,342 |
| Current assets |
160,840
|
195,190
|
284,072 |
| Current liabilities |
292,584
|
260,789
|
253,168 |
| Equity capital |
41,249
|
88,926
|
85,202 |
| - share capital |
5,750
|
5,763
|
5,763 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.5%
|
19.2%
|
20.2% |
| Turnover per employee |
802
|
967
|
840 |
| Profit as a percentage of turnover |
15.1%
|
30.5%
|
33.6% |
| Return on assets (ROA) | |||
| Current ratio |
55.0%
|
74.8%
|
112.2% |
| Return on equity (ROE) |
102.8%
|
116.2%
|
115.9% |
| Change turnover |
-57,083
|
44,775
|
98,162 |
| Change turnover % |
-17%
|
15%
|
50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.